Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Camelot Information Systems Slips To Loss In Q4 - Quick Facts

Camelot Information Systems Inc. (CIS: Quote) reported that its fourth-quarter net loss attributable to the company was $10.6 million, compared to net income of $0.5 million in the year-ago quarter. Loss per ADS for the quarter was $0.06, compared to profit of $0.01 per ADS last year.

Adjusted net loss attributable to Camelot was $4.5 million, as compared to adjusted net income of $2.7 million in the year-ago quarter.

Adjusted net income includes $3.9 million in compensation received in exchange for shares in a subsidiary.

Net revenues were $71.9 million in the fourth quarter of 2012, an increase of 20.4% from $59.7 million in the fourth quarter of 2011.

Click here to receive FREE breaking news email alerts for Camelot Information Systems Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Stocks moved notably higher over the course of the trading day on Friday after initially showing a lack of direction. The gains on the day extended the recent upward trend by the markets, with the tech-heavy Nasdaq reaching its best closing level in almost a month. Looking to capitalize on news of an Ebola diagnosis in New York City, Republican Senate candidate Scott Brown issued a statement Friday criticizing his Democratic opponent Sen. Jeanne Shaheen, D-N.H., for "waffling" on a travel ban. In another troubling sign for Democrats, the results of a Gallup poll released on Friday show that Tea Party Republicans are much more motivated to vote in the upcoming midterm elections than other Americans. The poll found that 73 percent of Tea Party Republicans are "extremely" or "very" motivated to vote in this year's elections.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.